Literature DB >> 31838571

A comparison of obesity indices in relation to mortality in type 2 diabetes: the Fremantle Diabetes Study.

Joel Tate1, Matthew Knuiman1, Wendy A Davis2, Timothy M E Davis2, David G Bruce3.   

Abstract

AIMS/HYPOTHESIS: This prospective association study aimed to compare the relationship between each of four obesity indices and mortality risk in people with type 2 diabetes.
METHODS: The associations of BMI, waist circumference, WHR and A Body Shape Index (ABSI) with all-cause mortality were analysed in 1282 participants of the Fremantle Diabetes Study, followed for up to 20 years after baseline assessment. Models were adjusted for age and other confounders; assessments as continuous measures and by quintile were carried out for men and women separately. Sensitivity analyses were conducted to minimise reverse causality.
RESULTS: When indices were assessed as continuous variables, there were significant bivariate associations with mortality for: ABSI, which was greater in both men and women who died (p < 0.001); WHR, which was greater in women only (p = 0.033); and BMI, which was lower in women only (p < 0.001). When assessed by quintile, there were significant bivariate associations with mortality for ABSI in men and women (p < 0.001) and BMI in women only (p = 0.002). In Cox models of time to death, adjusted for age, diabetes duration, ethnicity and smoking, ABSI quintiles showed a linear trend for both men (p = 0.003) and women (p = 0.035). Men in the fifth ABSI quintile had an increased mortality risk compared with those in the first quintile (HR [95% CI]: 1.74 [1.24, 2.44]) and women in the fifth ABSI quintile had an increased mortality risk that approached statistical significance (1.42 [0.97, 2.08], p = 0.08). Men in the fifth WHR quintile had an increased mortality risk (1.47 [1.05, 2.06]). There was no association between mortality and BMI or waist circumference in either sex. CONCLUSIONS/
INTERPRETATION: ABSI was the obesity index most strongly associated with all-cause mortality in Australians with type 2 diabetes. There was no evidence for an obesity paradox with any of the assessed indices. ABSI may be a better index of central obesity than waist circumference, BMI or WHR when assessing mortality risk in type 2 diabetes.

Entities:  

Keywords:  A Body Shape Index; Body Mass Index; Cohort study; Longitudinal study; Mortality; Obesity paradox; Type 2 diabetes; Waist Circumference; Waist-Hip ratio

Mesh:

Year:  2019        PMID: 31838571     DOI: 10.1007/s00125-019-05057-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus.

Authors:  Diewertje Sluik; Heiner Boeing; Jukka Montonen; Tobias Pischon; Rudolf Kaaks; Birgit Teucher; Anne Tjønneland; Jytte Halkjaer; Tina L Berentzen; Kim Overvad; Larraitz Arriola; Eva Ardanaz; Benedetta Bendinelli; Sara Grioni; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; Annemieke M W Spijkerman; Daphne L van der A; Joline W Beulens; Yvonne T van der Schouw; Peter M Nilsson; Bo Hedblad; Olov Rolandsson; Paul W Franks; Ute Nöthlings
Journal:  Am J Epidemiol       Date:  2011-05-26       Impact factor: 4.897

2.  Obesity in Older Adults: Epidemiology and Implications for Disability and Disease.

Authors:  Rafael Samper-Ternent; Soham Al Snih
Journal:  Rev Clin Gerontol       Date:  2012-02-01

3.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

4.  Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking.

Authors:  David A Jenkins; Jack Bowden; Heather A Robinson; Naveed Sattar; Ruth J F Loos; Martin K Rutter; Matthew Sperrin
Journal:  Diabetes Care       Date:  2018-07-03       Impact factor: 19.112

5.  Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Wendy A Davis; Eunice Chin; Adelle Jee; Jen Martins; David G Bruce; John Beilby; Timothy M E Davis
Journal:  Eur J Endocrinol       Date:  2010-08-06       Impact factor: 6.664

6.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

7.  Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults.

Authors:  Henry S Kahn; Kai McKeever Bullard; Lawrence E Barker; Giuseppina Imperatore
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 8.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

9.  Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

Authors:  J Q Purnell; J E Hokanson; S M Marcovina; M W Steffes; P A Cleary; J D Brunzell
Journal:  JAMA       Date:  1998-07-08       Impact factor: 157.335

10.  Commentary: The paradox of body mass index in obesity assessment: not a good index of adiposity, but not a bad index of cardio-metabolic risk.

Authors:  Jonathan C K Wells
Journal:  Int J Epidemiol       Date:  2014-04-01       Impact factor: 7.196

View more
  4 in total

Review 1.  The obesity paradox and diabetes.

Authors:  Giovanni Gravina; Federica Ferrari; Grazia Nebbiai
Journal:  Eat Weight Disord       Date:  2020-09-20       Impact factor: 4.652

2.  Association of Sarcopenia and A Body Shape Index With Overall and Cause-Specific Mortality.

Authors:  Yu-Shun Qiao; Xingyao Tang; Yin-He Chai; Hong-Jian Gong; Xin Zhang; Coen D A Stehouwer; Jian-Bo Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

3.  Comparison of the Ability of Anthropometric Indices to Predict the Risk of Diabetes Mellitus in South African Males: SANHANES-1.

Authors:  Machoene D Sekgala; Ronel Sewpaul; Maretha Opperman; Zandile J Mchiza
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

4.  Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study.

Authors:  Sarra Smati; Blandine Tramunt; Matthieu Wargny; Cyrielle Caussy; Bénédicte Gaborit; Camille Vatier; Bruno Vergès; Deborah Ancelle; Coralie Amadou; Leila A Bachir; Olivier Bourron; Christine Coffin-Boutreux; Sara Barraud; Anne Dorange; Bénédicte Fremy; Jean-François Gautier; Natacha Germain; Etienne Larger; Stéphanie Laugier-Robiolle; Laurent Meyer; Arnaud Monier; Isabelle Moura; Louis Potier; Nadia Sabbah; Dominique Seret-Bégué; Patrice Winiszewski; Matthieu Pichelin; Pierre-Jean Saulnier; Samy Hadjadj; Bertrand Cariou; Pierre Gourdy
Journal:  Diabetes Obes Metab       Date:  2020-11-06       Impact factor: 6.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.